About MDS Studio
MDS Studio is a venture capital firm founded in 2022. It is primarily based out of Newark, United States. As of Nov 2023, MDS Studio has invested in 25 companies. It primarily invests in Seed round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to Enterprise Applications and HealthTech. Most recently it participated in the $***** Seed round of Pepper A lot of funds co-invest with MDS Studio, with names like Merck sharing a substantial percentage of its portfolio. MDS Studio has team of 4 people including 2 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed
MDS Studio's List of Top Investments
MDS Studio has a portfolio of 25 companies. Their most notable investments are in Indygeneus and Pepper.Their portfolio spans across United States, Anguilla, Belgium and 3 more locations. They have invested in Life Sciences, Enterprise Applications, HealthTech and 3 other sectors, across stages such as Seed stage. Here is the list of top investments by MDS Studio:
1. BioCorteX
Developer of human-microbiome platform for drug development. The company applies deep technology to deliver effective therapeutics by leveraging the synergy between health and bacteria, viruses, and fungi. The company uses the carbon mirror platform, a first-principle computer simulation to understand drug-bacteria interactions.
Key facts about BioCorteX
- Founded Year: 2021
- Location: London (United Kingdom)
- Stage: Seed
- Total Funding till date: $5M
- Employee Count: 13 as on May 31, 2026
- Investors: Sofinnova Partners, Hoxton Ventures and 1 Other
- Latest Funding Round: Seed, Mar 28, 2023, $*****
- Highlight: Editors' Pick
Provider of process analytical technologies for advanced biomanufacturing. The company's flagship product is DynaCHIP, drops into existing mass spectrometry workflows that enables sample preparation exponentially. It also offers DynaMARK, which incorporates a data science module to generate on-demand measurements of the most important metrics for modern biopharma workflows.
Key facts about Andson Biotech
- Founded Year: 2021
- Location: Atlanta (United States)
- Stage: Series A
- Total Funding till date: $9.1M
- Employee Count: 17 as on May 31, 2026
- Investors: Phase Two Ventures, NIH and 2 Others
- Latest Funding Round: Series A, Oct 17, 2025, $*****
- Highlight: Editors' Pick

3. Gesund AI
Provider of clinical-grade AI solutions for regulatory compliance. The company provides an AI Assurance Platform for regulatory compliance, covering the entire AI-enabled medical device lifecycle. It comply with regulatory requirements, audits and validates medical AI solutions for safety, effectiveness and equity.
Key facts about Gesund AI
- Founded Year: 2021
- Location: Cambridge (United States)
- Stage: Seed
- Total Funding till date: $2M
- Employee Count: 10 as on May 31, 2026
- Investors: Merck, Northpond Ventures and 5 Others
- Latest Funding Round: Seed, Aug 25, 2023, $*****
- Highlight: Editors' Pick

4. Pepper
Key facts about Pepper
- Founded Year: 2021
- Location: Boston (United States)
- Stage: Seed
- Total Funding till date: $11.3M
- Employee Count: 8 as on Jul 01, 2024
- Investors: Silverton Partners, NFX and 4 Others
- Latest Funding Round: Seed, Nov 30, 2023, $*****
_1558495786655.png?format=webp&height=120&width=120)
5. Perceiv
Developer of digital infrastructure for managing complex neurological treatment workflows. This platform facilitates patient identification, eligibility screening, and safety monitoring for medical practices. It provides tools for standardized patient management, disease education, and clinical oversight to support the delivery of neurological therapies. The system enables secure data handling and automated clinical workflows to assist practitioners in coordinating care protocols.
Key facts about Perceiv
- Founded Year: 2018
- Location: Montreal (Canada)
- Stage: Seed
- Total Funding till date: $1.5M
- Employee Count: 6 as on May 31, 2026
- Investors: Invest Quebec, Plug and Play Tech Center and 6 Others
- Latest Funding Round: Seed, Dec 08, 2022, $*****
MDS Studio's Year-on-Year Investment Trends
MDS Studio has invested in 25 companies over the last 4 years, with an average of 0 new investment annually in the last 3 years. Its most recent first time investment was in Pepper.MDS Studio's Investments by Stage
MDS Studio has made 7 investments in Seed stage with an average round size of $1.43M.MDS Studio's Investments by Sector
MDS Studio has a diverse portfolio, with companies operating in the Enterprise Applications, HealthTech, Healthcare, Life Sciences and Vertical SaaS. Notably, it has invested in 21 Tech companies, 20 Enterprise (B2B) companies, 13 Software companies and at least 5 companies focusing on Saas.Sector | No. of Investments |
|---|---|
Enterprise Applications | 4 |
HealthTech | 4 |
Healthcare | 3 |
Life Sciences | 3 |
Vertical SaaS | 2 |
Others | 1 |
Note: We have considered here, only first round of investments
MDS Studio's Investments by Geography
MDS Studio has made most investments in United States (6), followed by Canada where it has made 1 investment.Country | No. of Investments |
|---|---|
United States | 6 |
Canada | 1 |
Note: We have considered here, only first round of investments
MDS Studio's recent investments
MDS Studio has not made any investment in 2026 so far.Here are the most recent investments by MDS Studio:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Nov 30, 2023 | United States | Seed | 9225 | [+4] | |
Jan 07, 2023 | United States | Seed | 9203 | - | |
Jan 07, 2023 | United States | Seed | 5285 | - | |
Jan 07, 2023 | United States | Seed | 9972 | - | |
Jan 07, 2023 | United States | Seed | 7330 | - |
Team profile of MDS Studio
MDS Studio has a team of 4 members including 2 Partners and 1 Principal located in United States. MDS Studio's team sits on the board of 1 company.Here is a list of all team members in MDS Studio:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Cambridge | - | - | |
Partner | - | |||
Principal | New York | - | - |
Co-investors of MDS Studio
Over the past 4 years, 16 investors have co-invested in MDS Studio's portfolio companies. This includes funds and angels.
- Invested before MDS Studio: 500 Global, NFX and 2 others have invested in rounds before MDS Studio. There is 1 company where 500 Global has invested before MDS Studio and 1 company where NFX has invested before MDS Studio.
- Top Co-investors of MDS Studio: 11 investors entered a company along with MDS Studio. These include investors like Merck (1 company).
- Invested after MDS Studio: Invest 101 fund (1 company) is the only investor which has invested in MDS Studio's portfolio after their investments.
Recent News related to MDS Studio
•
DANNCE.AI Raises $2.6M in Pre-Seed FundingFinSMEs•Nov 21, 2024•DANNCE.ai, LDV Capital, Glasswing Ventures, Leolion and 2 others
•
NFX & Merck Back Pepper Bio, the 'Google Maps for Drug Discovery,' with $6.5M to Streamline R&DWebwire•Nov 30, 2023•Pepper, NFX, Silverton Partners, MDS Studio and 3 others
•
Pepper wins $6.5m to develop ‘transomic’ drug discovery platformPharmaceutical Technology•Nov 30, 2023•Pepper, NFX, Silverton Partners, Mana Ventures and 3 others
•

